Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].
Occhipinti M, Brambilla M, Di Liello R, Ambrosini P, Lobianco L, Leporati R, Salvarezza M, Vitiello F, Marchesi S, Manglaviti S, Beninato T, Mazzeo L, Proto C, Prelaj A, Ferrara R, Della Corte CM, Lo Russo G, de Braud F, Ganzinelli M, Viscardi G. Occhipinti M, et al. Among authors: ferrara r. Crit Rev Oncol Hematol. 2024 Dec;204:104521. doi: 10.1016/j.critrevonc.2024.104521. Epub 2024 Sep 23. Crit Rev Oncol Hematol. 2024. PMID: 39317528 No abstract available.
Unleashing precision: A review of targeted approaches in pleural mesothelioma.
Occhipinti M, Brambilla M, Di Liello R, Ambrosini P, Lobianco L, Leporati R, Salvarezza M, Vitiello F, Marchesi S, Manglaviti S, Beninato T, Mazzeo L, Proto C, Prelaj A, Ferrara R, Della Corte CM, Lo Russo G, de Braud F, Ganzinelli M, Viscardi G. Occhipinti M, et al. Among authors: ferrara r. Crit Rev Oncol Hematol. 2024 Nov;203:104481. doi: 10.1016/j.critrevonc.2024.104481. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159705 Free article. Review.
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis.
Marinelli D, Nuccio A, Di Federico A, Ambrosi F, Bertoglio P, Faccioli E, Ferrara R, Ferro A, Giusti R, Guerrera F, Mammana M, Pittaro A, Sepulcri M, Viscardi G, Gallina FT. Marinelli D, et al. Among authors: ferrara r. J Thorac Oncol. 2024 Oct 9:S1556-0864(24)02374-8. doi: 10.1016/j.jtho.2024.09.1443. Online ahead of print. J Thorac Oncol. 2024. PMID: 39389220
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.
D'Ambrosio S, Salomone F, Vitale F, Avanzo A, Viggiano A, Liguori L, Ferrara R, Nuccio A, Viscardi G, Napolitano F, Santaniello A, Formisano L, Bianco R, Servetto A. D'Ambrosio S, et al. Among authors: ferrara r. Eur J Cancer. 2024 Dec;213:115077. doi: 10.1016/j.ejca.2024.115077. Epub 2024 Oct 20. Eur J Cancer. 2024. PMID: 39454538 Free article.
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Piccirillo MC, et al. Among authors: ferrara r. J Thorac Oncol. 2024 Nov;19(11):1578-1579. doi: 10.1016/j.jtho.2024.08.017. Epub 2024 Aug 24. J Thorac Oncol. 2024. PMID: 39186030 No abstract available.
The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment.
Bennati C, Ferrara R, Sangaletti S, Tamberi S, Spadoni A, Attisani G, Zanuso S, Longobardi J, Morigi A, Spreafico M, Zingaretti C, Fabbri F, Carlotti E, Fabbri E, Turci L, D'Arcangelo M. Bennati C, et al. Among authors: ferrara r. Clin Lung Cancer. 2024 Dec;25(8):e397-e401. doi: 10.1016/j.cllc.2024.07.008. Epub 2024 Jul 15. Clin Lung Cancer. 2024. PMID: 39191545 Free article.
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Arunachalam A, Keller SM, Samkari A, Gao S; KEYNOTE-671 Investigators. Spicer JD, et al. Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288781 Clinical Trial.
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.
Ogliari FR, Traverso A, Barbieri S, Montagna M, Chiabrando F, Versino E, Bosco A, Lin A, Ferrara R, Oresti S, Damiano G, Viganò MG, Ferrara M, Riva ST, Nuccio A, Venanzi FM, Vignale D, Cicala G, Palmisano A, Cascinu S, Gregorc V, Bulotta A, Esposito A, Tacchetti C, Reni M. Ogliari FR, et al. Among authors: ferrara r. Lung Cancer. 2024 Dec 31;199:108075. doi: 10.1016/j.lungcan.2024.108075. Online ahead of print. Lung Cancer. 2024. PMID: 39752796
Persistence, severity and reactivity thresholds in fish allergic patients sensitized to parvalbumin.
Vera-Berrios RN, Vázquez-Cortés S, Gonzalo-Fernández A, Bindslev-Jensen C, Clausen M, Ferrara R, Gunnbjornsdottir M, Jongejan L, Lewandowska-Polak A, Mari A, Papadopoulos N, Poulsen LK, Prado ND, Magadán SS, Schnoor H, Stavroulakis G, Versteeg SA, Witten M, van Ree R, Fernández-Rivas M. Vera-Berrios RN, et al. Among authors: ferrara r. J Allergy Clin Immunol Pract. 2024 Dec 26:S2213-2198(24)01275-3. doi: 10.1016/j.jaip.2024.12.026. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39732287
365 results